Document is current
Any future updates will be listed below
-
Authors
Batac, Ayel Luis R.
Merrill, Kaitlyn A.
Golding, Michael A. https://orcid.org/0000-0002-7426-3386
Bhamra, Manvir
Harbottle, Zoe
Kopsch, Isac
Wilking, Erik
Jonsson, Marina
Ekström, Sandra
Abrams, Elissa M.
Halbrich, Michelle A.
Simons, Elinor
Roos, Leslie E.
Keddy-Grant, Jill A.
Gerstner, Thomas V.
St-Vincent, Jo-Anne
Protudjer, Jennifer L. P.
-
Funding
Funding for this research was provided by:
Research Manitoba
- License Information
-
More Information
Article History
Received: 23 May 2023
Accepted: 9 November 2023
First Online: 29 November 2023
Declarations
:
: Ethical approval for the current study was provided by the University of Manitoba Health Research Ethics Board (HS24294:[H2020:426]). All participants whose data were collected as part of the current study provided their full and informed consent.
: Not applicable.
: AB: sits on the Manitoba/Saskatchewan Steering Committee for ImmUnity Canada. KM, MG, MB, ZH, IK, EW, MJ, SE, MH, LR, JK-G, TG, JS,: none. EA: Section Head for Anaphylaxis and Food Allergy, and a Member of the Board, for the Canadian Society of Allergy and Clinical Immunology; and an employee of the Public Health Agency of Canada; the views expressed are her own and not those of the public health agency. ES: reports consultancy for Sanofi Genzyme. JP is Section Head, Allied Health; and Co-Lead, Research Pillar for the Canadian Society of Allergy and Clinical Immunology, and is on the steering committee for Canada’s National Food Allergy Action Plan. She reports consulting for Ajonomoto Cambrooke, Novartis, Nutricia and ALK Abelló.
